Jefferies Group LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$1,185,000
+178.2%
130,920
+336.4%
0.01%
+400.0%
Q2 2018$426,000
+44.4%
30,000
+66.6%
0.00%
+100.0%
Q4 2017$295,000
+586.0%
18,005
+363.2%
0.00%
Q2 2015$43,000
-95.5%
3,887
-93.8%
0.00%
-100.0%
Q4 2014$961,000
+150.3%
63,167
+77.4%
0.01%
+100.0%
Q3 2014$384,000
-13.3%
35,615
-15.7%
0.00%
-25.0%
Q3 2013$443,000
+29.9%
42,224
-3.2%
0.00%0.0%
Q2 2013$341,00043,6000.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
FIC CAPITAL INC 875,284$2,670,0001.34%
NEXTHERA CAPITAL LP 503,000$1,534,0000.90%
Opaleye Management Inc. 400,000$1,220,0000.72%
WASATCH ADVISORS LP 7,256,260$22,132,0000.33%
Cormorant Asset Management, LP 650,000$1,983,0000.27%
Sicart Associates LLC 101,950$311,0000.22%
Baker Brothers Advisors 4,055,876$12,370,0000.12%
Leisure Capital Management 43,008$131,0000.12%
Piermont Capital Management Inc. 165,569$505,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 837,963$2,556,0000.10%
View complete list of SANGAMO THERAPEUTICS INC shareholders